These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 81328)

  • 1. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
    Nakamura K; Kazama M
    Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
    Yoshimura R; Satake K
    Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibitors of coagulation and fibrinolysis in diabetics].
    Tóthová E; Mechír J; Mudronová B; Petrásová D
    Vnitr Lek; 1988 Jun; 34(6):558-63. PubMed ID: 2457985
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical problems of the natural coagulation and fibrinolysis inhibitors--introduction (author's transl)].
    Aoki N
    Rinsho Ketsueki; 1978 Jul; 19(7):917-9. PubMed ID: 81326
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism].
    Panchenko VM; Vladimirova AV; Pastorova VE; Sukhanova SA
    Lab Delo; 1980; (11):671-5. PubMed ID: 6160300
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 7. Perturbation of fibrinolysis inhibitors in progressive systemic sclerosis.
    Rothschild B; Thompson LD; Chesney M; Pifer D
    Med Hypotheses; 1985 Mar; 16(3):253-60. PubMed ID: 2582228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
    Oguri T; Hosoi A
    Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical problems of the natural coagulation and fibrinolysis inhibitors--central nervous system (author's transl)].
    Maruyama I
    Rinsho Ketsueki; 1978 Jul; 19(7):920-6. PubMed ID: 702827
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural protease inhibitors to fibrinolysis in liver diseases.
    Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
    Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total antithrombin activity in healthy newborn infants].
    Jiménez R; Navarrete M; Trejos R; Mora LA; Jiménez E
    Bol Med Hosp Infant Mex; 1982 Jun; 39(6):405-8. PubMed ID: 6180759
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of platelet function, coagulation and fibrinolysis during induction of labour at term by prostaglandin F2alpha and oxytocin (author's transl)].
    Briel RC; Kidess E; Kunz S
    Z Geburtshilfe Perinatol; 1978 Jun; 182(3):238-42. PubMed ID: 80063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation and fibrinolysis alterations in renal failure (author's transl)].
    Rocha E; Sánchez Ibarrola A; Arrizabalaga B; Páramo JA; Purroy A
    Sangre (Barc); 1980; 25(5B):740-59. PubMed ID: 7008223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemocoagulative and fibrinolytic parameters in chronic obliterative vascular disease of the lower extremities].
    Avellone G; Abruzzese G; Mandalà V; Riolo FP; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(1):43-6. PubMed ID: 6165368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of the determination of VIII R:Ag, VIII:C, alpha 1-AT, alpha 2-MG, FBG, AT-III, ADP in chronic cor-pulmonale (38 cases)].
    Zheng LY
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(3):146-7, 191. PubMed ID: 2452705
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of some blood coagulation parameters in angiographically documented coronary arteriosclerosis].
    Panizza P; Majolino I; Nalli G; Mussini A
    Haematologica; 1981 Dec; 66(6):768-78. PubMed ID: 6175552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.